ES515897A0 - "procedimiento para la produccion de 1-azaxantona". - Google Patents

"procedimiento para la produccion de 1-azaxantona".

Info

Publication number
ES515897A0
ES515897A0 ES515897A ES515897A ES515897A0 ES 515897 A0 ES515897 A0 ES 515897A0 ES 515897 A ES515897 A ES 515897A ES 515897 A ES515897 A ES 515897A ES 515897 A0 ES515897 A0 ES 515897A0
Authority
ES
Spain
Prior art keywords
azaxanthone
agent
alkoxy
human
concentrated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES515897A
Other languages
English (en)
Spanish (es)
Other versions
ES8400441A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lacer SA
Original Assignee
Lacer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacer SA filed Critical Lacer SA
Publication of ES8400441A1 publication Critical patent/ES8400441A1/es
Publication of ES515897A0 publication Critical patent/ES515897A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES515897A 1981-09-25 1982-09-23 "procedimiento para la produccion de 1-azaxantona". Granted ES515897A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP81107651A EP0075607B1 (en) 1981-09-25 1981-09-25 1-azaxanthone for use as therapeutic agent, processes for its production and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ES8400441A1 ES8400441A1 (es) 1983-11-16
ES515897A0 true ES515897A0 (es) 1983-11-16

Family

ID=8187931

Family Applications (2)

Application Number Title Priority Date Filing Date
ES515897A Granted ES515897A0 (es) 1981-09-25 1982-09-23 "procedimiento para la produccion de 1-azaxantona".
ES515898A Expired ES8308886A1 (es) 1981-09-25 1982-09-23 "procedimiento para la produccion de 1-azaxantona".

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES515898A Expired ES8308886A1 (es) 1981-09-25 1982-09-23 "procedimiento para la produccion de 1-azaxantona".

Country Status (7)

Country Link
US (1) US4623648A (OSRAM)
EP (1) EP0075607B1 (OSRAM)
JP (1) JPS5867618A (OSRAM)
AT (1) ATE12072T1 (OSRAM)
DE (1) DE3169269D1 (OSRAM)
ES (2) ES515897A0 (OSRAM)
PT (2) PT75582A (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE902790A (fr) * 1984-07-12 1986-01-02 Sandoz Sa Procede de preparation de xanthones et de thioxanthones.
US5565413A (en) * 1994-12-06 1996-10-15 Zeneca Limited Substituted pyridyl phenyl ketone herbicides
EP0996436B1 (en) * 1997-03-03 2005-07-27 Sanofi-Aventis Pharmaceutical formulations containing poorly soluble drug substances
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
JP2008539047A (ja) 2005-04-28 2008-11-13 プロテウス バイオメディカル インコーポレイテッド ファーマインフォーマティックスシステム
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗
EP3395372B1 (en) 2009-02-20 2022-04-06 EnhanX Biopharm Inc. Glutathione-based drug delivery system
SG10201402069PA (en) 2009-05-06 2014-07-30 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803153A (en) 1970-11-16 1974-04-09 Schering Corp Benzopyrano pyridines
JPS5619350B2 (OSRAM) * 1972-07-21 1981-05-07
JPS5919113B2 (ja) * 1975-02-03 1984-05-02 ウェルファイド株式会社 新規なベンゾピラノピリジン誘導体の製法
JPS5195097A (ja) * 1975-02-08 1976-08-20 Benzopiranopirijinjudotainoseizoho

Also Published As

Publication number Publication date
JPH0354645B2 (OSRAM) 1991-08-20
JPS5867618A (ja) 1983-04-22
PT75581A (fr) 1982-10-01
US4623648A (en) 1986-11-18
PT75581B (fr) 1985-05-31
ES515898A0 (es) 1983-10-16
EP0075607A1 (en) 1983-04-06
EP0075607B1 (en) 1985-03-13
ES8400441A1 (es) 1983-11-16
PT75582A (fr) 1982-10-01
DE3169269D1 (en) 1985-04-18
ATE12072T1 (de) 1985-03-15
ES8308886A1 (es) 1983-10-16

Similar Documents

Publication Publication Date Title
FI71126C (fi) Foerfarande foer framstaellning av n-(1-alkyl- eller allyl -2-pyrrolidinylmetyl)-2-metoxi-4-amino- -5-alkylsulfonylbensamider
ES8703881A1 (es) Procedimiento para la fabricacion de derivados del acido &- (oxo-2 hexahidro-2,4,5,6,7,7a tieno (3,2-c)piridil-5) fenil acetico
ES8603863A1 (es) Un procedimiento para la preparacion de agentes inotropicos de quinolona.
ES515898A0 (es) "procedimiento para la produccion de 1-azaxantona".
Bachman et al. Quinoline Derivatives from 3-Nitro-4-hydroxyquinoline1
JPS60214787A (ja) ピラゾロピリジン誘導体．その製造方法及びその用途
EP0285278A3 (en) Method of treating anxiety with tetrahydrobenzûc,d¨indole-6-carboxamides
EP0087218B1 (en) Guanidine derivatives
CA1141766A (en) 8-aminoalkyl-4-alkylpsoralens
EP0332109A1 (en) Phenoxyalkylcarboxylic acid derivatives and process for their preparation
SE8102220L (sv) Anvendning av substituerade derivat av 4-fenyl-4-oxo-2-butensyra sasom lekemedel
ES2080726T3 (es) Compuestos aromaticos o heteroaromaticos nitrosustituidos para su utilizacion en el tratamiento del cancer.
ES8103071A1 (es) Procedimiento de preparacion de nuevos derivados aminicos del benzotiazol
ES8501763A1 (es) "procedimiento para la fabricacion de derivados de la tetrahidro-5.6.7.7. 4h-tieno (3, 2-c) piridinona-2
AR248394A1 (es) Procedimiento para obtener nuevos derivados de la n-bencilpiridina.
Cohen et al. Antiplasmodial action and chemical constitution Part I. Cinchona alkaloidal derivatives and allied substances
ZA917141B (en) 3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and their use as medicaments
EP0402862B1 (en) 8-Carboxy-1,2,3,4-tetrahydroquinolin-6-yl-acetic acid and process for its preparation
LT2199B (lt) 2-triazolidinono dariniu gavimo budas
US4259335A (en) 1-Methyl-4-piperidinol esters of 4-quinolinylamino benzoates and antiinflammatory and analgesic compositions and methods employing them
IE43311B1 (en) 1-methyl-2-(pyridyloxmyethyl)-5-nitroimidazoles and process for preparing them
FI81570C (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbar fenyl-(3-hexametyleniminopropyl)-keton.
JPH07116125B2 (ja) フェノキシアルキルカルボン酸誘導体及びその製造法
PL91775B1 (OSRAM)
NO154091C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylaminoimidazolin-derivater.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519